Author:
Andreieva S. V.,Korets K. V.,Skorohod I. M.,Starodub H. S.
Subject
Genetics,Agricultural and Biological Sciences (miscellaneous),Cell Biology
Reference22 articles.
1. Arber, D.A., Orazi, A., Hasserjian, R., et al., The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 2016, vol. 127, no. 20, pp. 2391–2405. https://doi.org/10.1182/blood-2016-03-643544
2. Avada, H., Thapa, B., and Visconte, V., The genomics of myelodysplastic Syndromes: origins of disease evolution, biological pathways, and prognostic implications, Cells, 2020, vol. 9, no. 11, art. ID 2512. https://doi.org/10.3390/cells9112512
3. Bacher, U., Haferlach, T., Schnittger, S., et al., Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact, Br. J. Haematol., 2014, vol. 164, no. 6, pp. 822–833. https://doi.org/10.1111/bjh.12710
4. Gersen, St.L., The Principles of Clinical Cytogenetics, New York: Springer-Verlag, 2013.
5. Gluzman, D., Sklyrenko, L., Koval, S., et al., Modern Classification and Diagnosis of Myelodysplastic Syndromes. Scientific-and-Methodical Quide, Kyiv: INTERSERVIS, 2018.